BACKGROUND Comparative outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary
between PCI and CABG at 3 years and 5 years of follow-up (11, 12) . We now report the very long-term (10-year) results of the MAIN-COMPARE study with a systematic linkage to data from a national population registry of vital statistics.
METHODS
STUDY DESIGN AND POPULATION. The design and enrollment characteristics of the MAIN-COMPARE study have been published previously (11, 12) . Inverse probability weighting that was based on the propensity score was used as the primary tool to adjust for differences in the baseline characteristics between the PCI and CABG groups (12) (13) (14) . For each comparison (the entire cohort, wave 1, and wave 2), a separate propensity score was derived. We examined the similarity of the baseline characteristics between treatment groups before and after inverse probability weighting (15) . The cumulative event curves were estimated with the use of a weighted Kaplan-Meier method.
To characterize the time-dependent nature of the relative risks of the treatment groups over time and to compensate for the violation of the proportionalhazards assumption for the treatment group variable (as evidenced by the crossing survival curves), we performed weighted piecewise Cox regression models with robust standard errors according to a prespecified time point at 5 years after index treatment.
Previous publications suggested no difference of mortality and hard clinical endpoints between PCI and CABG for LMCA disease up to 5 years (12, (16) (17) (18) .
Although it still unknown whether difference of treatment effect between PCI and CABG diverge or emerge over time beyond 5 years, the findings of EXCEL and NOBLE trials suggested a trend toward late catch-up or crossover of events favoring CABG over time (9, 10) and a significant benefit of CABG became evident from 5 years to 10 years of follow-up (19, 20) . Thus, a decision of a pre-specified time set of 5 years was made a priori on the basis of such findings from the available published reports. Hazard ratios The mean number of stents implanted in LMCA and per-patient was 1.2 AE 0.5 and 1.9 AE 1.1, respectively.
In patients who underwent CABG, 478 (42.0%) underwent off-pump surgery, and 1120 (98.4%) received at least 1 arterial conduit that, in 1,096 patients (97.9%), was used in revascularization of the left anterior descending artery. The mean number of grafts used was 2.9 AE 1.0 (2.2 AE 0.9 arterial grafts and 0.7 AE 0.8 venous grafts). Table 1 shows baseline characteristics of the study patients. Before adjustment with the use of inverse probability weighting, there were differences between the 2 groups in several of the baseline variables. Overall, patients undergoing CABG were older and had higher clinical and anatomic risk factor
Long-Term Outcomes of PCI vs. CABG for Left Main Disease profiles as compared with those undergoing PCI.
As expected, with regard to the distribution of propensity scores in the treatment groups, patients in the PCI group had a lower probability of being selected for CABG than did those in the CABG group (Online Figure 1 ). After adjustment with the use of inverse probability weighting, all the clinical covariates were well balanced ( Table 1 ). In general, as compared with patients enrolled in wave 1, patients enrolled in wave 2 had a higher risk profile of clinical and anatomic characteristics (Online Tables 1 and 2 ).
After propensity-score adjustment, baseline characteristics between PCI and CABG groups were also well balanced in each cohort of wave 1 and wave 2.
After propensity-score matching, 659 pairs of patients who underwent PCI and CABG were derived from the overall cohort (193 pairs in the wave 1 cohort and 432 pairs in the wave 2 cohort). After matching, Values are mean AE SD, median (interquartile range), or n (%), unless otherwise indicated. *The standardized differences are reported as percentages; a difference of <10.0% indicates a relatively small imbalance.
the standardized differences were <10.0% for all variables, indicating only small differences between the 2 groups ( Table 1, Online Tables 1 and 2 ). In the overall population, the adjusted risks for clinical events with the use of inverse probability weighting are shown in Figure 1 and Table 2 . There were no significant differences between the PCI and CABG groups with respect to the risks of death and SENSITIVITY AND SUBGROUP ANALYSES. In the sensitivity analyses using the propensity-score matching, overall findings were similar ( Table 2 BMS ¼ bare-metal stent(s); CI ¼ confidence interval; DES ¼ drug-eluting stent(s); HR ¼ hazard ratio; other abbreviations as in Table 1 .
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infarction or stroke with the use of inverse probability weighting and propensity-score matching is shown in Online Table 3 .
The results of subgroup analyses using the inverseprobability-of-treatment weighting reflected the broad consistency of the relative effect of PCI and CABG (Online Figures 8 to 10 ). An exception was the nominally significant interactions of treatment with the left main disease location (ostial or shaft vs.
distal bifurcation) with respect to the rates of death and composite outcome. other abbreviations as in Figure 1 .
Long-Term Outcomes of PCI vs. CABG for Left Main Disease benefit of CABG has diverged over time during continued follow-up. The rate of target-vessel failure was consistently higher in the PCI group.
Our findings should be evaluated in the context of results from recent other studies. In the EXCEL study, PCI was noninferior to CABG with respect to primary composite of death, stroke, or myocardial infarction at 3 years (9). The primary events were less common after PCI within 30 days, whereas fewer primary endpoint events occurred in the CABG group between 30 days and 3 years. Also, all-cause mortality tended to be higher after PCI than after CABG at complete 3-year follow-up (8.0% vs. 5.8%; p ¼ 0.08). In the NOBLE study, CABG was better than PCI for major adverse cardiac or cerebrovascular events up to 5 years (10), when the advantages of CABG over PCI diverged over time. But, a recent meta-analysis suggested no mortality benefit of CABG over PCI in patients with left main disease up to 5 years (18).
As noted in prior studies (9) (10) (11) (12) , the relative benefit of CABG and PCI has been different substantially over time, but until recently, long-term studies up to 10 years were limited (21) . Limited follow-up could penalize the CABG group, because the long-term advantages of CABG does not become fully evident until 5 to 10 years after revascularization (20, 22) .
In this Further study is required to determine the extent to which these differences contributed to the observed results. Finally, our study evaluated the first generation of DES. Previously, our reports did not find any meaningful difference in clinical outcomes among several types of first-and second-generation DES for LMCA disease (7, 17, 27, 28) . However, our findings should be compared with those of the extended follow-up of EXCEL and NOBLE trials using contemporary DES. Long-Term Outcomes of PCI vs. CABG for Left Main Disease
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